ArticleJournal of vascular surgery2025
Racial and ethnic minority groups, female sex, and tissue loss are associated with increased risk for hospital readmission following revascularization for chronic limb-threatening ischemia.
Article in Journal of vascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundUnplanned hospital readmission following surgery for peripheral arterial disease is among the highest in all diagnosis-related groups. Although previous studies have examined readmissions in certain subgroups, such as for patients undergoing lower extremity bypass, few have examined longer term readmissions for those with the most severe form of peripheral arterial disease, chronic limb-threatening ischemia (CLTI). Among patients with CLTI undergoing revascularization, we sought to outline rates of readmission beyond 30 days up to 1 year and identify patient and procedural characteristics associated with readmission.
methodsWe identified patients by Current Procedural Terminology codes from January 6, 2020, to May 25, 2022, and collected demographic, operative, and 1-year outcomes data. We used univariate and multivariable modeling to assess factors associated with hospital readmission.
resultsOf the 247 patients who underwent intervention for CLTI, 130 patients (53%) were readmitted within 1 year, primarily for revascularization-related problems. The most common indications for readmission within 30 days and 1 year were wound infection and tissue breakdown (48.3% and 37.7%, respectively) and new rest pain or tissue loss (13.8% and 20.8%, respectively). The only cause of readmission considered nonmodifiable was undergoing a staged procedure. Overall, 96.6% and 96.9% of readmissions within 30 days and 1 year were potentially modifiable (ie, wound infection and tissue breakdown, new rest pain or tissue loss, graft thrombosis, sepsis, and myocardial infarction). After multivariable adjustment, racial and ethnic minority groups (odds ratio [OR], 2.6; P = .009), female sex (OR, 2.1; P = .031), and tissue loss as an indication (OR, 4.1; P = .0002) were associated with readmission within 30 days. At 1 year, only racial and ethnic minority status (OR, 2.6; P = .007) and a tissue loss indication (OR, 2.1; P = .011) were associated with readmissions. Patient age, comorbidity burden, area deprivation index, and intervention type (endovascular vs open) were not significantly associated with 30-day or 1-year readmissions. Racial and ethnic minority groups (P = .014), female sex (P = .05), acute kidney injury (P = .014), and index hospital length of stay (P = .009) were associated with multiple readmissions. Number of readmissions was not associated with risk of major limb amputation.
conclusionsPostoperative readmission among patients with CLTI is high and occurs primarily for wound infections and new rest pain or tissue loss. Overall, the majority of readmissions were for potentially modifiable factors. Racial and ethnic minority groups and female patients undergoing revascularization for tissue loss are at greatest risk for readmissions. These data support the investigation of interventions targeting these high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.